Cambridge Based Biotech, Phico Therapeutics, Announces Milestone in the Fight Against Multidrug Resistant Bacteria Enzyme NDM-1
9/12/2012 11:05:49 AM
More...
|
Quotient BioResearch Announces Agreement with Phico Therapeutics and First Application of Rapidfact for Nasal Delivery
9/13/2011 11:57:46 AM
More...
|
As Saspject Enters Phase II Phico Therapeutics Announces Dr Anthony F. Martin as Board Chairman
11/1/2010 2:16:04 PM
More...
|
Wellcome Trust Award-Winning Company Phico Therapeutics Announces Success of Safety and Tolerability Trial
6/10/2010 2:26:24 PM
More...
|
Wellcome Trust Award-Winning Company Phico Therapeutics Releases New SASPject PT1.2 Efficacy Data at ICCAC
9/15/2009 1:45:05 PM
More...
|
Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust
1/28/2009 10:02:56 AM
More...
|